Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.
Tarakji KG, Mittal S, Kennergren C, Corey R, Poole JE, Schloss E, Gallastegui J, Pickett RA, Evonich R, Philippon F, McComb JM, Roark SF, Sorrentino D, Sholevar D, Cronin E, Berman B, Riggio D, Biffi M, Khan H, Silver MT, Collier J, Eldadah Z, Wright DJ, Lande JD, Lexcen DR, Cheng A, Wilkoff BL; WRAP-IT Investigators. Tarakji KG, et al. Among authors: eldadah z. N Engl J Med. 2019 May 16;380(20):1895-1905. doi: 10.1056/NEJMoa1901111. Epub 2019 Mar 17. N Engl J Med. 2019. PMID: 30883056 Free article. Clinical Trial.
Edoxaban versus warfarin in patients with atrial fibrillation.
Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators. Giugliano RP, et al. N Engl J Med. 2013 Nov 28;369(22):2093-104. doi: 10.1056/NEJMoa1310907. Epub 2013 Nov 19. N Engl J Med. 2013. PMID: 24251359 Free article. Clinical Trial.
Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD).
Zhang Y, Kennedy R, Blasco-Colmenares E, Butcher B, Norgard S, Eldadah Z, Dickfeld T, Ellenbogen KA, Marine JE, Guallar E, Tomaselli GF, Cheng A. Zhang Y, et al. Among authors: eldadah z. Heart Rhythm. 2014 Aug;11(8):1377-83. doi: 10.1016/j.hrthm.2014.04.039. Epub 2014 May 2. Heart Rhythm. 2014. PMID: 24793459 Free PMC article.
Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD).
Cheng A, Zhang Y, Blasco-Colmenares E, Dalal D, Butcher B, Norgard S, Eldadah Z, Ellenbogen KA, Dickfeld T, Spragg DD, Marine JE, Guallar E, Tomaselli GF. Cheng A, et al. Among authors: eldadah z. Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1084-91. doi: 10.1161/CIRCEP.113.001705. Epub 2014 Oct 1. Circ Arrhythm Electrophysiol. 2014. PMID: 25273351 Free PMC article.
Clinical and serum-based markers are associated with death within 1 year of de novo implant in primary prevention ICD recipients.
Zhang Y, Guallar E, Blasco-Colmenares E, Dalal D, Butcher B, Norgard S, Tjong FV, Eldadah Z, Dickfeld T, Ellenbogen KA, Marine JE, Tomaselli GF, Cheng A. Zhang Y, et al. Among authors: eldadah z. Heart Rhythm. 2015 Feb;12(2):360-6. doi: 10.1016/j.hrthm.2014.10.034. Epub 2014 Oct 30. Heart Rhythm. 2015. PMID: 25446153 Free PMC article.
Changes in Follow-Up Left Ventricular Ejection Fraction Associated With Outcomes in Primary Prevention Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Recipients.
Zhang Y, Guallar E, Blasco-Colmenares E, Butcher B, Norgard S, Nauffal V, Marine JE, Eldadah Z, Dickfeld T, Ellenbogen KA, Tomaselli GF, Cheng A. Zhang Y, et al. Among authors: eldadah z. J Am Coll Cardiol. 2015 Aug 4;66(5):524-31. doi: 10.1016/j.jacc.2015.05.057. J Am Coll Cardiol. 2015. PMID: 26227190 Free PMC article.
Cost-Effectiveness of an Antibacterial Envelope for Cardiac Implantable Electronic Device Infection Prevention in the US Healthcare System From the WRAP-IT Trial.
Wilkoff BL, Boriani G, Mittal S, Poole JE, Kennergren C, Corey GR, Krahn AD, Schloss EJ, Gallastegui JL, Pickett RA, Evonich RF, Roark SF, Sorrentino DM, Sholevar DP, Cronin EM, Berman BJ, Riggio DW, Khan HH, Silver MT, Collier J, Eldadah Z, Holbrook R, Lande JD, Lexcen DR, Seshadri S, Tarakji KG. Wilkoff BL, et al. Among authors: eldadah z. Circ Arrhythm Electrophysiol. 2020 Oct;13(10):e008503. doi: 10.1161/CIRCEP.120.008503. Epub 2020 Sep 11. Circ Arrhythm Electrophysiol. 2020. PMID: 32915063 Free PMC article.
Low-temperature electrocautery reduces adverse effects from secondary cardiac implantable electronic device procedures: Insights from the WRAP-IT trial.
Mittal S, Wilkoff BL, Poole JE, Kennergren C, Wright DJ, Berman BJ, Riggio D, Sholevar DP, Martinez-Arraras J, Moubarak JB, Schaller RD, Love JC, Pickett RA, Philippon F, Eldadah Z, Lande JD, Lexcen DR, Holbrook R, Tarakji KG. Mittal S, et al. Among authors: eldadah z. Heart Rhythm. 2021 Jul;18(7):1142-1150. doi: 10.1016/j.hrthm.2021.03.033. Epub 2021 Mar 27. Heart Rhythm. 2021. PMID: 33781980 Free article. Clinical Trial.
49 results